- Liver Disease and Transplantation
- Sepsis Diagnosis and Treatment
- Cardiac tumors and thrombi
- Drug-Induced Hepatotoxicity and Protection
- Protein purification and stability
- Electrocatalysts for Energy Conversion
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Immune Response and Inflammation
- Liver Disease Diagnosis and Treatment
- Pulmonary Hypertension Research and Treatments
- Healthcare Policy and Management
- Asthma and respiratory diseases
- Monoclonal and Polyclonal Antibodies Research
- Fuel Cells and Related Materials
- Electrolyte and hormonal disorders
- Soft tissue tumor case studies
- Emergency and Acute Care Studies
- Patient Safety and Medication Errors
- Biosimilars and Bioanalytical Methods
- Medical Imaging and Pathology Studies
- IgG4-Related and Inflammatory Diseases
- Inflammation biomarkers and pathways
- Respiratory and Cough-Related Research
- Vascular Anomalies and Treatments
Mills Peninsula Health Services
2021
Pulmonary Associates
2021
University of California, Los Angeles
2011-2017
VA Greater Los Angeles Healthcare System
2015
UCLA Medical Center
2013
Tufts University
2010
Pulmonary tumor thrombotic microangiopathy (PTTM) is a disease process wherein cells are thought to embolize the pulmonary circulation causing hypertension (PH) and death from right heart failure. Presented herein clinical, laboratory, radiographic, histologic features across seven cases of PTTM. Highlighted in this publication also involvement venules clinical distinguishing PTTM mimics. We conducted retrospective chart review hospitals greater Los Angeles metropolitan area. Patients series...
With the rapid growth of monoclonal antibody-based products, new technologies have emerged for creating modified forms antibodies, including fragments, conjugates and multi-specific antibodies. We created a database 450 therapeutic antibodies in development to determine which indications will constitute "next generation" antibody products. conclude that future closely resemble already been approved commercial sale.
Patients with acute liver failure have high rates of infections, likely from defects in immune function. Whether infections are independently associated poor outcomes is unclear. We hypothesized that patients injury who developed were at increased risk adverse outcomes.We conducted a retrospective analysis 150 critically ill adult admitted dysfunction single academic institution between 2005 and 2011. excluded immunocompromised states, chronic disease died or discharged within 48 h...
Significant resources have been allocated to decreasing the number of preventable deaths in hospitals, but identifying factors and then leveraging them effect system-wide change remains challenging.To determine ability a novel in-person, multidisciplinary "rapid mortality review" process identify that are action items lead improvements care.Rapid review sessions were conducted weekly for patients who died medical intensive care unit. Patient data clinician opinions regarding discussed...
In this narrative medicine essay, a pulmonologist learns about process improvement from his father, an engineer, who drew up list of 50 improvements he noted during hospitalizations for prostate cancer.